GSK has penned another neuroscience pact, this time with Danish biotech Muna Therapeutics. | GSK has penned another ...
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
GSK has understood the game of access in Egypt earlier than other companies. By buying two successful local manufacturing facilities with their generic brands, GSK has better market access than ...
Once the companies are satisfied with the target, GSK will be in charge of taking the programs forward. It will lead drug ...
GSK, Gilead and Arcellx, Vertex and more present new data at the American Society of Hematology annual meeting just as sickle cell therapies Casgevy and Lyfgenia have a new outcomes-based payment ...
With that in mind, GSK is partnering with developer Reef and investor UBS Asset Management to build a 1.4M SF, £900M life ...
The partnership revolves around Muna Therapeutics’ technology platform, which employs a spatial multi-omics approach to ...
Novavax will sell its Czech manufacturing factory to Novo Nordisk for $200 million. Takeda announced it will pay $200 million ...
Muna will take the lead in identifying and validating new Alzheimer’s targets, while GSK will be responsible for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback